All News

The GSK RSV vaccine candidate has received favorable international regulatory attention which may be an auspicious sign for the US.

Breast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.

Which states have the most binge drinkers? Or the most alcohol-related deaths? A recent analysis provides answers.

The findings underscore the importance of routine eGFR and UACR screening in primary care to ensure early detection of CKD and avoid related adverse outcomes.

In patients with prediabetes and untreated type 2 diabetes, a reduced carbohydrate diet improved HbA1c and other metabolic markers vs a usual diet.

To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Efficacy of the RZV vaccine against herpes zoster infection remained >80% in a long-term follow-up study representing 10 years since initial immunization.

High-dose dexamethasone is often prescribed for critically ill COVID-19 patients although there is no evidence for its efficacy. A new study looked deeper.

Your daily dose of clinical news you may have missed.

IDWeek 2022: New data show a greater than 60% reduction in acute exacerbations and need for antibiotics in patients with CS who used fluticasone propionate nasal spray.

The overall US COVID-19 vaccination picture has both bright spots and dark areas. Get a quick look at details from the most recent KFF Vaccine Monitor survey.

The high-dose influenza vaccines provided greater relative vaccine effectiveness/efficacy vs standard dose in a cohort of more than 45 million.

Your daily dose of clinical news you may have missed.

CMHC 2022: Patients with NASH are often not diagnosed until an advanced stage, and have a high burden of comorbidities, according to new study.

CHEST. After a moderate COPD event, treatment with TT within 30 days significantly reduced risk for exacerbation over 12 months vs treatment after 30 days.

Gabapentin-involved overdose deaths doubled in Q2 2020 compared to Q1 2019, the CDC reports. What do you know, and maybe not know, about the troubling trend?